A feasibility study of intravenous (IV) paclitaxel, intraperitoneal (IP) carboplatin, and IP paclitaxel in patients with epithelial ovarian carcinoma, fallopian tube carcinoma, or peritoneal carcinoma

被引:0
作者
Nagao, S. [1 ]
Oishi, R. [1 ]
Iwasa, N. [1 ]
Shimizu, M. [1 ]
Hasegawa, K. [1 ]
Goto, T. [1 ]
Fujiwara, K. [1 ]
机构
[1] Saitama Med Univ Int, Med Ctr, Hidaka City, Saitama, Japan
关键词
D O I
暂无
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
e16549
引用
收藏
页数:2
相关论文
共 50 条
[31]   Phase II trial of intraperitoneal cisplatin combined with intravenous paclitaxel in patients with ovarian, primary peritoneal and fallopian tube cancer [J].
Landrum, Lisa M. ;
Hyde, Johnny, Jr. ;
Mannel, Robert S. ;
McMeekin, D. Scott ;
Moore, Kathleen N. ;
Walker, Joan L. .
GYNECOLOGIC ONCOLOGY, 2011, 122 (03) :527-531
[32]   Paclitaxel-based chemotherapy in carcinoma of the Fallopian tube [J].
Gemignani, ML ;
Hensley, ML ;
Cohen, R ;
Venkatraman, E ;
Saigo, PE ;
Barakat, RR .
GYNECOLOGIC ONCOLOGY, 2001, 80 (01) :16-20
[33]   Survival and toxicity of a modified GOG 172 IP chemotherapy regimen in patients with ovarian, fallopian tube or primary peritoneal carcinoma [J].
Becker, D. ;
Haygood, C. L. Walters ;
Smith, B. ;
Bevis, K. S. .
GYNECOLOGIC ONCOLOGY, 2015, 137 :176-177
[34]   Phase II study of intraperitoneal submicron particle paclitaxel (SPP) plus IV carboplatin and paclitaxel in patients with epithelial ovarian cancersurgery [J].
Mullany, Sally ;
Miller, David Scott ;
Robison, Katina ;
Levinson, Kimberly ;
Lee, Yi-Chun ;
Yamada, S. Diane ;
Walker, Joan ;
Markman, Maurie ;
Marin, Alyson ;
Mast, Peter ;
diZerega, Gere .
GYNECOLOGIC ONCOLOGY REPORTS, 2020, 34
[35]   Randomized Phase II/III Trial Of 3 Vs 6 Courses Of Neoadjuvant Carboplatin-Paclitaxel Chemotherapy In Stage IIIC Or IV Epithelial Ovarian, Fallopian Tube Or Primary Peritoneal Carcinoma [J].
Zamagni, Claudio ;
Fagotti, Anna ;
Rubino, Daniela ;
Salutari, Vanda ;
De Leo, Antonio ;
Perrone, Anna Myriam ;
Cacciari, Nicoletta ;
Bernardi, Alessandra ;
Quercia, Sara ;
Pizzirani, Cinzia ;
Paccapelo, Alexandro ;
Mandrioli, Anna ;
Palluzzi, Eleonora ;
Cubelli, Marta ;
Perri, Maria Teresa ;
Giunchi, Susanna ;
Fontana, Tommaso ;
Scambia, Giovanni ;
De Iaco, Pierandrea .
INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER, 2025, 35 (02)
[36]   Liposomal doxorubicin in sequential doublet combination with paclitaxel and carboplatin in patients with primary epithelial ovarian or primary peritoneal carcinoma. [J].
Method, MW ;
Rodriguez, M .
JOURNAL OF CLINICAL ONCOLOGY, 2004, 22 (14) :472S-472S
[37]   A phase I dose-escalation study of intraperitoneal (IP) cisplatin, IV/IP paclitaxel, IV bevacizumab, and oral olaparib for newly diagnosed adenxal carcinoma. [J].
Konner, Jason A. ;
Boucicaut, Nicole N. ;
O'Cearbhaill, Roisin Eilish ;
Zamarin, Dmitriy ;
Makker, Vicky ;
Sabbatini, Paul ;
Tew, William P. ;
Cadoo, Karen Anne ;
Grisham, Rachel N. ;
Aghajanian, Carol .
JOURNAL OF CLINICAL ONCOLOGY, 2017, 35
[38]   A DOUBLE-BLIND, PLACEBO CONTROLLED,PHASE II CHEMOIMMUNOTHERAPY (PACLITAXEL CARBOPLATIN-OREGOVOMAB) VS CHEMOTHERAPY (PACLITAXEL-CARBOPLATIN-PLACEBO) AS NEOADJUVANT THERAPY INPATIENTS WITH ADVANCED EPITHELIAL OVARIAN, FALLOPIAN TUBE OR PERITONEAL CARCINOMA [J].
Bhatt, Niraj ;
Korant, Rajesh ;
Kalloli, Mahesh ;
Ramesh, Anita ;
Kumar, Vijay ;
Ganesan, T. S. ;
Ravishankar, B. ;
Pavithran, K. ;
Kandipalli, Shilpa ;
Yoon, Evelyn ;
Yoon, Ben ;
Teja, Tl Raj ;
Gupta, Sunil ;
Jada, Srinivasa Rao .
INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER, 2023, 33 (SUPPL_4) :A251-A251
[39]   Combined weekly carboplatin and paclitaxel as primary treatment of advanced epithelial ovarian carcinoma [J].
Safra, Tamar ;
Menczer, Joseph ;
Bernstein, Rinat Molho ;
Shpigel, Shulem ;
Matcejevsky, Dianna ;
Inbar, Moshe J. ;
Golan, Abraham ;
Grisaru, Dan ;
Levy, Tally .
GYNECOLOGIC ONCOLOGY, 2009, 114 (02) :215-218
[40]   Third-line chemotherapy in platinum- and paclitaxel-resistant ovarian, fallopian tube, and primary peritoneal carcinoma patients [J].
Tangjitgamol, S ;
See, HT ;
Manusirivithaya, S ;
Levenback, CF ;
Gershenson, DM ;
Kavanagh, JJ .
INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER, 2004, 14 (05) :804-814